Clinical Trial Update: AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial RADICAL evaluating AZD4547 with anastrozole or letrozole in ER-positive breast cancer patients who progressed on NSAIs has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AZD4547
• Anastrozole (Anastrozole)
• Letrozole (letrozole)

Snippet

Sponsor: Imperial College London | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-08-22